These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 15010646

  • 1. Microalbuminuria in type 2 diabetics: an important, overlooked cardiovascular risk factor.
    Weir MR.
    J Clin Hypertens (Greenwich); 2004 Mar; 6(3):134-41; quiz 142-3. PubMed ID: 15010646
    [Abstract] [Full Text] [Related]

  • 2. Treatment of microalbuminuria in patients with type 2 diabetes mellitus.
    Jerums G, MacIsaac RJ.
    Treat Endocrinol; 2002 Mar; 1(3):163-73. PubMed ID: 15799209
    [Abstract] [Full Text] [Related]

  • 3. Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes.
    Donnelly R, Yeung JM, Manning G.
    J Hypertens Suppl; 2003 Mar; 21(1):S7-12. PubMed ID: 12769161
    [Abstract] [Full Text] [Related]

  • 4. Drug treatment for hypertensive patients in special situations: diabetes and hypertension.
    Mogensen CE.
    Clin Exp Hypertens; 1999 Mar; 21(5-6):895-906. PubMed ID: 10423111
    [Abstract] [Full Text] [Related]

  • 5. [Microalbuminuria: cardiovascular and renal risk factors underestimated in clinical practice].
    Zanella MT.
    Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):313-21. PubMed ID: 16767297
    [Abstract] [Full Text] [Related]

  • 6. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D.
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [Abstract] [Full Text] [Related]

  • 7. Microalbuminuria: a marker to increased renal and cardiovascular risk in diabetes mellitus.
    McKenna K, Thompson C.
    Scott Med J; 1997 Aug; 42(4):99-104. PubMed ID: 9507584
    [Abstract] [Full Text] [Related]

  • 8. Relationships among diabetes, microalbuminuria, and ACE inhibition.
    de Cotret PR.
    J Cardiovasc Pharmacol; 1998 Aug; 32 Suppl 2():S9-17. PubMed ID: 9736436
    [Abstract] [Full Text] [Related]

  • 9. Slowing progression along the renal disease continuum.
    Kopyt NP.
    J Am Osteopath Assoc; 2005 Apr; 105(4):207-15. PubMed ID: 15928338
    [Abstract] [Full Text] [Related]

  • 10. [Risk and prevention of diabetic nephropathy].
    Ravera M, Re M, Deferrari G.
    G Ital Nefrol; 2007 Apr; 24 Suppl 38():13-9. PubMed ID: 17922442
    [Abstract] [Full Text] [Related]

  • 11. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus.
    Valmadrid CT, Klein R, Moss SE, Klein BE.
    Arch Intern Med; 2000 Apr 24; 160(8):1093-100. PubMed ID: 10789601
    [Abstract] [Full Text] [Related]

  • 12. [Control of arterial pressure in diabetic nephropathy].
    Luño J, García de Vinuesa S.
    Nefrologia; 2001 Apr 24; 21(3):240-5. PubMed ID: 11471304
    [No Abstract] [Full Text] [Related]

  • 13. [Microalbuminuria is an early marker for increased morbidity and mortality].
    Bramlage P, Wittchen HU, Pittrow D, Dikow R, Kirch W, Lehnert H, Ritz E.
    Fortschr Med Orig; 2003 Feb 27; 121 Suppl 1():28-32. PubMed ID: 14732947
    [Abstract] [Full Text] [Related]

  • 14. The role of angiotensin II antagonism in type 2 diabetes mellitus: a review of renoprotection studies.
    Zanella MT, Ribeiro AB.
    Clin Ther; 2002 Jul 27; 24(7):1019-34. PubMed ID: 12182249
    [Abstract] [Full Text] [Related]

  • 15. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
    Dalla Vestra M, Pozza G, Mosca A, Grazioli V, Lapolla A, Fioretto P, Crepaldi G.
    Diabetes Nutr Metab; 2004 Oct 27; 17(5):259-66. PubMed ID: 16295047
    [Abstract] [Full Text] [Related]

  • 16. The link between microalbuminuria, endothelial dysfunction and cardiovascular disease in diabetes.
    Naidoo DP.
    Cardiovasc J S Afr; 2002 Oct 27; 13(4):194-9. PubMed ID: 12389063
    [Abstract] [Full Text] [Related]

  • 17. Renal function, glycemic control and perindopril in diabetic patients.
    Brichard S, Ketelslegers JM, Lambert AE.
    Clin Exp Hypertens A; 1989 Oct 27; 11 Suppl 2():545-54. PubMed ID: 2691128
    [Abstract] [Full Text] [Related]

  • 18. [Should normotensive diabetic patients with microalbuminuria be treated with angiotensin converting enzyme inhibitors?].
    Feldt-Rasmussen BF.
    Ugeskr Laeger; 2002 Apr 01; 164(14):1907-9. PubMed ID: 11957423
    [No Abstract] [Full Text] [Related]

  • 19. The RAAS in the pathogenesis and treatment of diabetic nephropathy.
    Ruggenenti P, Cravedi P, Remuzzi G.
    Nat Rev Nephrol; 2010 Jun 01; 6(6):319-30. PubMed ID: 20440277
    [Abstract] [Full Text] [Related]

  • 20. [Diabetes, hypertension and microalbuminuria in primary care].
    Bramlage P, Wittchen HU, Pittrow D, Dikow R, Kirch W, Lehnert H, Ritz E.
    Fortschr Med Orig; 2003 Feb 27; 121 Suppl 1():33-8. PubMed ID: 14732948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.